Journal of Clinical Endocrinology & Metabolism, Vol 77, 731-737, Copyright © 1993 by Endocrine Society

ARTICLES

Regulation of human adrenal carcinoma cell (NCI-H295) production of C19 steroids

WE Rainey, IM Bird, C Sawetawan, NA Hanley, JL McCarthy, EA McGee, R Wester and JI Mason
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center, Dallas 75235.

The regulation of biosynthesis of the adrenal C19 steroids (the so- called adrenal androgens) remains unclear. Understanding adrenal production of C19 steroids is important when the benefits of these steroids are considered on processes and diseases associated with aging. In vitro studies defining the mechanisms that regulate the production of human adrenal C19 steroids have been limited because of the difficulties in obtaining adrenal tissue. A cell line that retains differentiated adrenal functions would greatly facilitate research in this area. Herein, we describe the use of the human adrenocortical tumor H295 cell line as a model to evaluate mechanisms controlling C19 and C21 steroid production. The cells were characterized with regard to ACTH, forskolin, and dibutyryl cAMP (dbcAMP) responsiveness, as measured by increased cAMP production, synthesis of steroids, and induction of 17 alpha-hydroxylase cytochrome P450 (P450c17). Forskolin and dbcAMP, which were more effective than ACTH, enhanced the production of cortisol, dehydroepiandrosterone (DHEA), DHEA sulfate (DHEAS), and androstenedione over a 48-h treatment period. Comparison of the relative amounts of measured steroid secreted under forskolin treatment indicated that the primary product was cortisol (70%), followed by androstenedione (14%), DHEA (9%), and DHEAS (7%). Cortisol was also demonstrated to be the major steroid product by examination of UV-detectable steroids after high performance liquid chromatographic separation. The increases in steroid production caused by ACTH, forskolin, and dbcAMP occurred in a concentration- and time-dependent manner. A key enzyme in the production of C19 steroids is P450c17. ACTH, forskolin, and dbcAMP increased the activity of 17 alpha- hydroxylase by approximately 2.5-, 10-, and 10-fold, respectively. These effects on enzyme activity occurred in a concentration-dependent manner and coincided with increased levels of P450c17 mRNA. In summary, H295 cells should provide a much-needed model to study mechanisms controlling the secretion of glucocorticoids and C19 steroids, because steroid production in these cells is hormonally controlled and associated with the induction of P450c17.

This article has been cited by other articles:

				E. F Nogueira, C. A Vargas, M. Otis, N. Gallo-Payet, W. B Bollag, and W. E Rainey Angiotensin-II acute regulation of rapid response genes in human, bovine, and rat adrenocortical cells J. Mol. Endocrinol., December 1, 2007; 39(6): 365 - 374. [Abstract] [Full Text] [PDF]

				E. Samandari, P. Kempna, J.-M. Nuoffer, G. Hofer, P. E Mullis, and C. E Fluck Human adrenal corticocarcinoma NCI-H295R cells produce more androgens than NCI-H295A cells and differ in 3{beta}-hydroxysteroid dehydrogenase type 2 and 17,20 lyase activities J. Endocrinol., December 1, 2007; 195(3): 459 - 472. [Abstract] [Full Text] [PDF]

				D. G. Romero, S. Rilli, M. W. Plonczynski, L. L. Yanes, M. Y. Zhou, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez Adrenal transcription regulatory genes modulated by angiotensin II and their role in steroidogenesis Physiol Genomics, June 19, 2007; 30(1): 26 - 34. [Abstract] [Full Text] [PDF]

				A. R. Asif, M. Ljubojevic, I. Sabolic, V. Shnitsar, M. Metten, N. Anzai, G. A. Muller, G. Burckhardt, and Y. Hagos Regulation of steroid hormone biosynthesis enzymes and organic anion transporters by forskolin and DHEA-S treatment in adrenocortical cells Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1351 - E1359. [Abstract] [Full Text] [PDF]

				J. T. Sanderson The Steroid Hormone Biosynthesis Pathway as a Target for Endocrine-Disrupting Chemicals Toxicol. Sci., November 1, 2006; 94(1): 3 - 21. [Abstract] [Full Text] [PDF]

				N. Huang, A. Dardis, and W. L. Miller Regulation of Cytochrome b5 Gene Transcription by Sp3, GATA-6, and Steroidogenic Factor 1 in Human Adrenal NCI-H295A Cells Mol. Endocrinol., August 1, 2005; 19(8): 2020 - 2034. [Abstract] [Full Text] [PDF]

				D. G. Romero, M. Plonczynski, G. R. Vergara, E. P. Gomez-Sanchez, and C. E. Gomez-Sanchez Angiotensin II early regulated genes in H295R human adrenocortical cells Physiol Genomics, September 16, 2004; 19(1): 106 - 116. [Abstract] [Full Text] [PDF]

				K. Hilscherova, P. D. Jones, T. Gracia, J. L. Newsted, X. Zhang, J. T. Sanderson, R. M. K. Yu, R. S. S. Wu, and J. P. Giesy Assessment of the Effects of Chemicals on the Expression of Ten Steroidogenic Genes in the H295R Cell Line Using Real-Time PCR Toxicol. Sci., September 1, 2004; 81(1): 78 - 89. [Abstract] [Full Text] [PDF]

				Ch.V. Rao, X.L. Zhou, and Z.M. Lei Functional Luteinizing Hormone/Chorionic Gonadotropin Receptors in Human Adrenal Cortical H295R Cells Biol Reprod, August 1, 2004; 71(2): 579 - 587. [Abstract] [Full Text] [PDF]

				A.-M. Lefrancois-Martinez, J. Bertherat, P. Val, C. Tournaire, N. Gallo-Payet, D. Hyndman, G. Veyssiere, X. Bertagna, C. Jean, and A. Martinez Decreased Expression of Cyclic Adenosine Monophosphate-Regulated Aldose Reductase (AKR1B1) Is Associated with Malignancy in Human Sporadic Adrenocortical Tumors J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3010 - 3019. [Abstract] [Full Text] [PDF]

				J. T. Sanderson, L. Slobbe, G. W. A. Lansbergen, S. Safe, and M. van den Berg 2,3,7,8-Tetrachlorodibenzo-p-dioxin and Diindolylmethanes Differentially Induce Cytochrome P450 1A1, 1B1, and 19 in H295R Human Adrenocortical Carcinoma Cells Toxicol. Sci., May 1, 2001; 61(1): 40 - 48. [Abstract] [Full Text] [PDF]

				N. A. Hanley, W. E. Rainey, D. I. Wilson, S. G. Ball, and K. L. Parker Expression Profiles of SF-1, DAX1, and CYP17 in the Human Fetal Adrenal Gland: Potential Interactions in Gene Regulation Mol. Endocrinol., January 1, 2001; 15(1): 57 - 68. [Abstract] [Full Text]

				C. Le Roy, J. Y. Li, D. M. Stocco, D. Langlois, and J. M. Saez Regulation by Adrenocorticotropin (ACTH), Angiotensin II, Transforming Growth Factor-{beta}, and Insulin-Like Growth Factor I of Bovine Adrenal Cell Steroidogenic Capacity and Expression of ACTH Receptor, Steroidogenic Acute Regulatory Protein, Cytochrome P450c17, and 3{beta}-Hydroxysteroid Dehydrogenase Endocrinology, May 1, 2000; 141(5): 1599 - 1607. [Abstract] [Full Text] [PDF]

				J. T. Sanderson, W. Seinen, J. P. Giesy, and M. van den Berg 2-Chloro-s-Triazine Herbicides Induce Aromatase (CYP19) Activity in H295R Human Adrenocortical Carcinoma Cells: A Novel Mechanism for Estrogenicity? Toxicol. Sci., March 1, 2000; 54(1): 121 - 127. [Abstract] [Full Text] [PDF]

				G. A. Hines and R. Azziz Impact of Architectural Disruption on Adrenocortical Steroidogenesis In Vitro J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 1017 - 1021. [Abstract] [Full Text]

				J. S. Gell, J. Oh, W. E. Rainey, and B. R. Carr Effect of Estradiol on DHEAS Production in the Human Adrenocortical Cell Line, H295R Reproductive Sciences, May 1, 1998; 5(3): 144 - 148. [Abstract] [PDF]

				I. M. Bird, J. I. Mason, and W. E. Rainey Protein Kinase A, Protein Kinase C, and Ca2+-Regulated Expression of 21-Hydroxylase Cytochrome P450 in H295R Human Adrenocortical Cells J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1592 - 1597. [Abstract] [Full Text]

				H. Rodriguez, D. W. Hum, B. Staels, and W. L. Miller Transcription of the Human Genes for Cytochrome P450scc and P450c17 Is Regulated Differently in Human Adrenal NCI-H295 Cells Than in Mouse Adrenal Y1 Cells J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 365 - 371. [Abstract] [Full Text] [PDF]